服薬コンプライアンスモニタリング市場 - 第1版

2022年末において、世界中で440万台のコネクテッド服薬コンプライアンスモニタリングデバイスが使用されています。市場は今後数年間、CAGRで13.2％の成長を示し、稼働台数は2027年までに820万台に達する見込みです。

当レポートでは、服薬コンプライアンスモニタリング市場について調査分析し、主なデバイスとサービス、主要企業43社の戦略、将来の市場と技術開発の予測などの情報を提供しています。

目次

図のリスト

エグゼクティブサマリー

第1章 慢性疾患の課題

• イントロダクション
  • 老年人口
• 慢性疾患
  • 心血管疾患
  • 慢性呼吸器疾患
  • 糖尿病
• 医療システム
  • 北米の医療
  • 欧州の医療
  • アジア太平洋の医療
• 規制環境
  • 北米の規制環境
  • 欧州の規制環境
  • その他の主要市場における規制環境
  • 医療データ規制
  • 標準化
• 償還環境

第2章 服薬コンプライアンスモニタリング

• 市場の概要
• フォームファクターと使用事例
  • 注射薬ソリューション
  • 吸入薬ソリューション
  • 薬瓶、ディスペンサーソリューション
• 既存の服薬コンプライアンス技術の課題
• 注射薬ソリューションプロバイダー
  • Beta Bionics
  • Bigfoot Biomedical
  • Biocorp
  • Credence MedSystems
  • Eli Lilly and Company
  • Innovation Zed
  • Insulet Corporation
  • Medtronic
  • Medtrum Technologies
  • Merck Group
  • Noble International (Aptar Group)
  • Novo Nordisk
  • Phillips-Medisize
  • Roche
  • Tandem Diabetes Care
  • Ypsomed
• 吸入薬ソリューションプロバイダー
  • Adherium
  • Amiko Digital Health
  • Aptar Group
  • Cognita Labs
  • FindAir
  • NuvoAir
  • Propeller Health
  • Teva Pharmaceutical Industries
• 薬瓶、ディスペンサーソリューションプロバイダー
  • AARDEX Group
  • AceAge
  • AdhereTech
  • Compliance Meds Technologies
  • Evondos Group
  • Hero Health
  • Information Mediary Corporation
  • iZafe Group
  • Legrand Care
  • Medimi
  • MedMinder
  • MedReady
  • PharmAdva
  • SMRxT
  • Spencer Health Solutions
  • Vaica
• 服薬コンプライアンス包装ソリューションプロバイダー
  • Schreiner MediPharm
  • WestRock
• デジタルピル
  • etectRx

第3章 市場の予測と動向

• ベンダー情勢
• 市場の分析と予測
  • 注射薬コンプライアンスモニタリングソリューション
  • 吸入薬コンプライアンスモニタリングソリューション
  • 薬瓶、ディスペンサーソリューション
• 市場動向
  • コネクテッド服薬管理市場が勢いを増している
  • AIベースの吸入器の発売により呼吸器ケア市場に革命が起きる
  • COVID-19がmヘルスソリューションの成長の触媒となった
  • 医療従事者の不足により効率的な医療が求められる
  • 摂取可能なバイオセンサー技術の進歩
  • 遠隔患者モニタリングからデータドリブン患者エンゲージメントへ
  • ソリューションベンダーは持続可能性に関心を示している
  • 金銭的インセンティブを調整する有利な政策がRPMの採用を推進している
  • 成長する市場と新規参入企業により市場情勢は変化する
  • 従来のドラッグデリバリーからスマートドラッグデリバリーへの選好の変化
  • BYODは遠隔医療の一般的なオプションとなった
  • M&Aがコネクテッド服薬の技術情勢を動かす
  • デジタルヘルス市場への投資の関心の高まり
  • 高齢化により医療費が増加する
• 頭字語と略語のリスト

List of Figures

• Figure 1.1: Population by age group and region
• Figure 1.2: Prevalence of diabetes by region (World 2021)
• Figure 1.3: Share of the population covered by private health insurance (2021)
• Figure 1.4: Total health expenditure per capita by country (2021)
• Figure 1.5: Total and per capita healthcare expenditure by country (North America 2021)
• Figure 1.6: Healthcare spending by type of service and product (Canada 2022)
• Figure 1.7: Health insurance coverage by type of insurance (US 2021)
• Figure 1.8: Healthcare spending by type of service and product (US 2021)
• Figure 1.9: Summary of RPM and RTM codes
• Figure 2.1: Common causes of medication non-adherence
• Figure 2.2: Examples of medication management solutions
• Figure 2.3: Pill bottle and dispenser solution types
• Figure 2.4: Injected medication solution providers and their product offerings
• Figure 2.5: Current and forthcoming insulin-pump devices
• Figure 2.6: Bigfoot Biomedical Unity system
• Figure 2.7: Eli Lilly's Tempo Personalized Diabetes Management Platform
• Figure 2.8: Medtronic Diabetes revenues by sub-segment (World 2022)
• Figure 2.9: Phillips-Medisize Aria Smart Autoinjector
• Figure 2.10: Roche mySugr app
• Figure 2.11: The FindAir asthma management app and inhaler sensor
• Figure 2.12: Propeller Health's asthma management app and inhaler sensor
• Figure 2.13: Teva Respiratory Digihaler system
• Figure 2.14: The AdhereTech smart pill bottle
• Figure 2.15: The Hero Health smart medication dispenser
• Figure 2.16: The Spencer SmartHub from Spencer Health Solutions
• Figure 2.17: Schreiner MediPharm Smart Blister Wallet and Smart Blister Card
• Figure 3.1: Medication management solutions by form factor
• Figure 3.2: Medication compliance monitoring devices by segment (World 2021-2027)
• Figure 3.3: Medication compliance monitoring market value (World 2021-2027)
• Figure 3.4: Leading injected medication solution providers (2022)
• Figure 3.5: Leading connected pill bottle and dispenser solution providers (World 2022)
• Figure 3.6: Strategic activity in the connected medication compliance market (2019-2023)
• Figure 3.7: Elderly population (65+) as a percentage of total population

How should the mobile industry address the vast business opportunity in wireless healthcare monitoring? There were 4.4 million connected medication compliance monitoring devices being used worldwide at the end of 2022. The market is forecasted to grow at a compound annual growth rate (CAGR) of 13.2 percent during the next years to reach an installed base of 8.2 million units by 2027. Medication compliance monitoring solutions include injected medication solutions, inhaled medication solutions as well as pill bottles and dispensers. Learn more about how wireless technology can become seamlessly integrated with these devices in this 120 - page in-depth report.

This report will allow you to:

• Profit from numerous executive interviews with market leading companies.

• Learn about key medication compliance monitoring devices and services.

• Study the strategies of 43 key players in the medication compliance monitoring ecosystem.

• Understand the market dynamics in North America, Europe and the Rest of World.

• Comprehend how technology can become seamlessly integrated with medical devices.

• Evaluate the business opportunities in the emerging medication adherence monitoring segment.

• Predict future market and technology developments.

Table of Contents

Table of Contents

List of Figures

Executive Summary

1. The Challenge of Chronic Diseases

• 1.1. Introduction
  • 1.1.1. The ageing population
• 1.2. Chronic diseases
  • 1.2.1. Cardiovascular diseases
  • 1.2.2. Chronic respiratory diseases
  • 1.2.3. Diabetes
• 1.3. Healthcare systems
  • 1.3.1. Healthcare in North America
  • 1.3.2. Healthcare in Europe
  • 1.3.3. Healthcare in Asia-Pacific
• 1.4. The regulatory environment
  • 1.4.1. Regulatory environment in North America
  • 1.4.2. Regulatory environment in Europe
  • 1.4.3. Regulatory environment in other major markets
  • 1.4.4. Medical data regulations
  • 1.4.5. Standardisation
• 1.5. The reimbursement environment

2. Medication Compliance Monitoring

• 2.1. Market overview
• 2.2. Form factors and use cases
  • 2.2.1. Injected medication solutions
  • 2.2.2. Inhaled medication solutions
  • 2.2.3. Pill bottle and dispenser solutions
• 2.3. Challenges with existing medication compliance technologies
• 2.4. Injected medication solution providers
  • 2.4.1. Beta Bionics
  • 2.4.2. Bigfoot Biomedical
  • 2.4.3. Biocorp
  • 2.4.4. Credence MedSystems
  • 2.4.5. Eli Lilly and Company
  • 2.4.6. Innovation Zed
  • 2.4.7. Insulet Corporation
  • 2.4.8. Medtronic
  • 2.4.9. Medtrum Technologies
  • 2.4.10. Merck Group
  • 2.4.11. Noble International (Aptar Group)
  • 2.4.12. Novo Nordisk
  • 2.4.13. Phillips-Medisize
  • 2.4.14. Roche
  • 2.4.15. Tandem Diabetes Care
  • 2.4.16. Ypsomed
• 2.5. Inhaled medication solution providers
  • 2.5.1. Adherium
  • 2.5.2. Amiko Digital Health
  • 2.5.3. Aptar Group
  • 2.5.4. Cognita Labs
  • 2.5.5. FindAir
  • 2.5.6. NuvoAir
  • 2.5.7. Propeller Health
  • 2.5.8. Teva Pharmaceutical Industries
• 2.6. Pill bottle and dispenser solution providers
  • 2.6.1. AARDEX Group
  • 2.6.2. AceAge
  • 2.6.3. AdhereTech
  • 2.6.4. Compliance Meds Technologies
  • 2.6.5. Evondos Group
  • 2.6.6. Hero Health
  • 2.6.7. Information Mediary Corporation
  • 2.6.8. iZafe Group
  • 2.6.9. Legrand Care
  • 2.6.10. Medimi
  • 2.6.11. MedMinder
  • 2.6.12. MedReady
  • 2.6.13. PharmAdva
  • 2.6.14. SMRxT
  • 2.6.15. Spencer Health Solutions
  • 2.6.16. Vaica
• 2.7. Medication compliance packaging solution providers
  • 2.7.1. Schreiner MediPharm
  • 2.7.2. WestRock
• 2.8. Digital Pills
  • 2.8.1. etectRx

3. Market Forecasts and Trends

• 3.1. Vendor landscape
• 3.2. Market analysis and forecasts
  • 3.2.1. Injected medication compliance monitoring solutions
  • 3.2.2. Inhaled medication compliance monitoring solutions
  • 3.2.3. Pill bottle and dispenser solutions
• 3.3. Market trends
  • 3.3.1. The market for connected medication management is gaining traction
  • 3.3.2. Launch of AI-based inhalers are revolutionizing the respiratory care market
  • 3.3.3. COVID-19 became a catalyst for the growth of mHealth solutions
  • 3.3.4. Healthcare staff shortages calls for efficient healthcare
  • 3.3.5. Advancing ingestible biosensor technology
  • 3.3.6. From remote patient monitoring to data-driven patient engagement
  • 3.3.7. Solution vendors show interest in sustainability
  • 3.3.8. Favourable policies that align financial incentives are driving RPM adoption
  • 3.3.9. A growing market and new entrants lead to a changing market landscape
  • 3.3.10. Shift in preference from traditional drug delivery to smart drug delivery
  • 3.3.11. BYOD has become a common option for telehealth
  • 3.3.12. M&As drive consolidation in the connected medication technology landscape
  • 3.3.13. Growing investment interest in the digital health market
  • 3.3.14. An ageing population increases healthcare expenditures
• List of Acronyms and Abbreviations